Brennan Daniel J. — SEC Form 4 filings
SEC reporting owner CIK 1595612. 15 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-02-08 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 5 filings — 235,376 shares, $20,744,598 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 65.
- Largest priced transaction: sale of 67,333 shares @ $105.24 ($7,086,111) in BOSTON SCIENTIFIC CORP, filed 2025-02-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | 10 | — | 8 legs · 235,376 sh · $20,744,598 | 55 |
| WATERS CORP /DE/ (WAT) | Director | 3 | — | — | 6 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | 2 | — | — | 4 |
Form 4 filings — Brennan Daniel J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 404 @ $0 · Grant/award (A): 681 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | WATERS CORP /DE/ (WAT) | Grant/award (A): 23 @ $0 · Grant/award (A): 57 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | WATERS CORP /DE/ (WAT) | Grant/award (A): 307 @ $0 · Grant/award (A): 828 (derivative) @ $0 | EDGAR |
| 2025-08-05 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 967 @ $0 · Grant/award (A): 1,705 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Sale (S): 2,900 @ $104.08 · Sale (S): 14,630 @ $104.67 · Option exercise (M): 18,533 @ $24.55 · Option exercise (M): 16,865 @ $17.26 · Option exercise (M): 15,642 @ $27.09 · Option exercise (M): 9,483 @ $40.12 · +5 more | EDGAR |
| 2025-02-18 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 4,362 @ $0 · Tax withholding (F): 2,110 @ $106.11 · Option exercise (M): 4,243 @ $0 · Tax withholding (F): 2,052 @ $106.11 · Option exercise (M): 4,584 @ $0 · Tax withholding (F): 2,217 @ $106.11 · +5 more | EDGAR |
| 2025-02-14 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 3,654 @ $0 · Tax withholding (F): 1,767 @ $105.77 · Option exercise (M): 3,654 (derivative) @ $0 | EDGAR |
| 2025-02-13 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 33,944 @ $0 · Tax withholding (F): 16,414 @ $105.98 · Option exercise (M): 15,087 @ $16.31 · Sale (S): 15,087 @ $105.07 · Option exercise (M): 15,087 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | WATERS CORP /DE/ (WAT) | Grant/award (A): 319 @ $0 · Grant/award (A): 818 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 14,901 @ $0 · Tax withholding (F): 5,212 @ $89.32 · Sale (S): 9,689 @ $89.86 · Option exercise (M): 14,901 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 16,863 @ $24.55 · Option exercise (M): 16,863 @ $17.26 · Option exercise (M): 15,642 @ $27.09 · Option exercise (M): 15,086 @ $16.31 · Sale (S): 64,454 @ $75.91 · Sale (S): 47,621 @ $75.11 · +4 more | EDGAR |
| 2024-02-20 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 4,243 @ $0 · Tax withholding (F): 1,882 @ $65.82 · Option exercise (M): 4,583 @ $0 · Tax withholding (F): 2,033 @ $65.82 · Option exercise (M): 3,706 @ $0 · Tax withholding (F): 1,644 @ $65.82 · +6 more | EDGAR |
| 2024-02-16 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 4,362 @ $0 · Tax withholding (F): 1,935 @ $65.95 · Option exercise (M): 4,362 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 14,617 (derivative) @ $0 · Grant/award (A): 38,537 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 36,666 @ $0 · Tax withholding (F): 16,262 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1595612 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →